Leadership Team

kronenberg-leadership2.jpgMitchell Kronenberg, Ph.D.
President & Chief Scientific Officer
Contact

Dr. Kronenberg is an internationally recognized scientist and one of the most highly cited immunologists in the world. This distinction is held by less than one half of one percent of all publishing scientific authors.  Dr. Kronenberg was appointed President of La Jolla Institute for Allergy & Immunology (LIAI) in September 2003.  In addition to his executive duties, he serves as Chief Scientific Officer and conducts an active research program.  

President & Chief Scientific OfficerHe received his Ph.D. from the California Institute of Technology in 1983, and stayed on to complete his postdoctoral work before joining the faculty of the UCLA School of Medicine in 1986.  At UCLA, he rose through the ranks to full professor.  In 1997, he came to La Jolla Institute to head the Division of Developmental Immunology, a position he held for 14 years, before stepping down recently to devote more time to his duties as President and Chief Scientific Officer.

Over the years, Dr. Kronenberg has received many major awards, most recently a prestigious Merit Award for scientific achievement from the National Institutes of Health. He has also been a Burroughs Wellcome Fund Visiting Professor at Harvard University and recently was asked to deliver the Joseph S. Ingraham immunology lecture at the Indiana University School of Medicine.

 

 

 

 

 

 

 

 

founding director
Dr. Kimishige Ishizaka served in the dual role of President and Scientific Director of LIAI until his retirement in 1996. He is currently President Emeritus of LIAI and also on the LIAI Board of Directors as a Director Emeritus.

Read "My Resume" by Dr. Kimi Ishizaka translated by Katsuji Sugie, M.D., Ph.D., (DI-1a) from the Japanese newspaper "Nihon Keizai Shinbun."
how to help
news
  • 1/23/2012 - La Jolla Institute Scientist Takes Quest to Conquer Type 1 Diabetes to the Next Level
    Learn More
  • 1/12/2012 - La Jolla Institute Researchers Identify Pivotal Immune Cell in Type 1 Diabetes in Humans
    Learn More
  • 12/24/2011 -  San Diego Union-Tribune Top 5 San Diego Science Stories of 2011 | La Jolla Institute Highlighted in Stem Cell Central
    Article link | .pdf
upcoming seminars
  • Maki Nakayama, "Insulin TcR transgenic mice and TcR and diabetes penetrance" Wednesday 08/17/11: 12:00 PM
  • Casey Weaver, "Sequential Actions of Innate and Adaptive Immune Cells in Intestinal Antibacterial Defense: A Shared Role for IL-22" Thursday 08/25/11: 12:00 PM
  • More Seminars